Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Theralase Signs Agreement with University of Manitoba

<< Previous

Bullboard Posts

Next >>

Comment by TriumphSpitSixon Feb 12, 2021 5:32pm

172 Views

Post# 32556367

RE:RE:RE:Theralase Signs Agreement with University of Manitoba

I hope they soon publish some kind of analysis utilizing PDCs on actual SARS-COV-II instead of "physiochemical" similars. All the covid panic has been based on the virus's novelty and ability to mutate into variations. I don't give much credence to positive tests on Zika virus and Swine flu.

Test covid and publish THOSE results, then maybe I'll break a sweat.

<< Previous

Bullboard Posts

Next >>

As AI expands, where can investors look for strong growth?